R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2022
Back to search
Official data from USPTO
CSL BEHRING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CSL BEHRING
ST13
US500000088675262Class
5, 9, 10, 16, 35, 40, 41, 42, 44
Filing
88675262
Registration
6655943
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/16/2025
Trademark type
Word
Nice classes
5, 9, 10, 16, 35, 40, 41, 42, 44
Filing date
10/31/2019
Registration date
03/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/01/2022
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
King of Prussia, PA
Examiner
JENKINS JR, CHARLES
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CSL Behring LLC
Representatives
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 16Class 35Class 40Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for blood diseasesillnesses and conditions; Pharmaceutical preparations for the treatment or prevention of blood and bleeding disorders; diagnostic preparation for medicinal purposes
Class 9
Electronic publicationsnewsletters and manuals featuring medical information and health treatment information recorded on computer media; Downloadable educational course materials in the field of health and medical treatment
Class 10
Apparatus of blood analysis; blood testing apparatus
Class 16
Printed matterprinted periodicalsnewslettersbrochures all in the fields of healthmedicine and pharmaceuticals; publicationshand-outs in the fields of healthmedicinetreatment and pharmaceuticals; Printed instructionaleducationalteaching materials in the field of healthmedicinepharmaceuticals and treatment; Informational flyers featuring healthmedicinepharmaceuticals and treatment information; Brochures about healthmedicinepharmaceuticals and treatment; Pamphlets in the field of healthmedicinepharmaceuticals and treatment information; posters; instruction sheets in the field of healthmedicinepharmaceuticals and treatment; Printed instructionaleducationalteaching materials in the field of healthmedicinepharmaceuticals and treatment
Class 35
Provision of information relating to wholesale and retail services in the pharmaceutical industry; Provision of information relating to promotion services in the field of promoting awareness of blood diseasesillnesses and conditions and treatment or prevention of blood and bleeding disorderspromoting awareness of pharmaceutical and health treatments
Class 40
Treatment of biological productscustom manufacturing and fractionation of blood; Processing of human blood plasmaremoving whole blood and separating red blood cells from plasma; treatment of biological productscustom manufacturing and fractionation of blood; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasmaremoving whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma
Class 41
Education servicesproviding classesseminarsworkshops in the field of continuing medical education and health education; Educational servicesproviding online instruction in the field of healthmedicinepharmaceuticals and medical treatment via an online website; Electronic publicationsnewsletters in the field of healthmedicinepharmaceuticals and treatment
Class 42
Scientific and technological researchscientific testing and screening servicestesting of human blood plasma for safety and quality; research and development of scientificmedicalpharmaceutical and blood products; Product research and development services; Laboratory analysismedical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals; management of scientific research projectsconducting scientific research; Pharmaceutical research services; scientific testing and screening servicestesting of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma
Class 44
Medical information services; health care information services; medical diagnostic testingmonitoring and reporting services; patient support servicesproviding information to patients in the field of administering medications; medical information concerning pharmaceuticalsmedical products and blood products; Medical testing for diagnostic or treatment purposes; medical testing of human blood plasma; collectionprocessing and testing of human blood and plasma for medical purposes
Publications
History of USPTO decisions and trademark events.
34 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/14/2021
PUBO
PUBLISHED FOR OPPOSITION
12/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2021
GNRT
NON-FINAL ACTION E-MAILED
11/03/2021
CNRT
NON-FINAL ACTION WRITTEN
11/03/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/01/2021
PBMR
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
10/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/20/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/13/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/13/2021
CNSI
SUSPENSION INQUIRY WRITTEN
05/13/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/13/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/13/2020
CNSL
SUSPENSION LETTER WRITTEN
10/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2020
ALIE
ASSIGNED TO LIE
09/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2020
GNRT
NON-FINAL ACTION E-MAILED
02/13/2020
CNRT
NON-FINAL ACTION WRITTEN
02/13/2020
DOCK
ASSIGNED TO EXAMINER
02/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2019
NWAP
NEW APPLICATION ENTERED
11/04/2019
Continuous trademark protection
Get notified about every new filing that threatens CSL BEHRING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.